Cargando…

New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological Malignancies

Bloodstream infections (BSI) are a significant cause of morbidity and mortality in onco-hematologic patients. The Gram-negative bacteria were the main responsible for the febrile neutropenia in the sixties; their impact declined due to the use of fluoroquinolone prophylaxis. This situation was follo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menzo, Sara Lo, la Martire, Giulia, Ceccarelli, Giancarlo, Venditti, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500473/ https://www.ncbi.nlm.nih.gov/pubmed/26185609 http://dx.doi.org/10.4084/MJHID.2015.044

Ejemplares similares

38. Predicting stenotrophomonas Maltophilia bloodstream Infections (BSI) in the Hematologic Malignancy Population
por: Karaba, Sara M, et al.
Publicado: (2020)

The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection
por: Di Domenico, Enea Gino, et al.
Publicado: (2021)

PB2587: BLOODSTREAM INFECTIONS AMONG PATIENTS WITH HEMATOLOGICAL MALIGNANCY IN ARMENIA
por: Soghomonyan, Diana, et al.
Publicado: (2023)

Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies
por: Wang, Jinjin, et al.
Publicado: (2023)

Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients With Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2019)

Extensively drug-resistant Gram-negative bacterial bloodstream infection in hematological disease
por: Zhou, Li, et al.
Publicado: (2019)

Editorial: Epidemiological trends in hematological malignancies
por: de Lima, Marcos, et al.
Publicado: (2023)

186. The Role of Repeated Blood Cultures in Hematologic Malignancy Patients with Neutropenic Fever due to Gram-Negative Bacterial Bloodstream Infections
por: Dhanaraj, Nitya, et al.
Publicado: (2023)

Bloodstream infections in patients with hematological malignancies: which is more fatal – cancer or resistant pathogens?
por: Gedik, Habip, et al.
Publicado: (2014)

1595. Impact of Levofloxacin for the Prophylaxis of Bloodstream Infection on the Gut Microbiome in Patients with Hematologic Malignancy
por: Ziegler, Matthew, et al.
Publicado: (2018)

Analysis of Risk Factors and Clinical Indicators in Bloodstream Infections Among Patients with Hematological Malignancy
por: Ma, Yating, et al.
Publicado: (2020)

Epidemiology of subsequent bloodstream infections in the ICU
por: Buetti, Niccolò, et al.
Publicado: (2018)

Risk Prediction and Prognosis of Invasive Fungal Disease in Hematological Malignancies Patients Complicated with Bloodstream Infections
por: Xiao, Han, et al.
Publicado: (2020)

Clinical Characteristics and Prognosis of Bloodstream Infection with Carbapenem-Resistant Pseudomonas aeruginosa in Patients with Hematologic Malignancies
por: Yuan, Fangfang, et al.
Publicado: (2023)

Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
por: Royo-Cebrecos, Cristina, et al.
Publicado: (2022)

Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis
por: Weber, Sarah, et al.
Publicado: (2021)

Risk Factors for Mortality and Outcomes in Hematological Malignancy Patients with Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections
por: Meng, Haiyang, et al.
Publicado: (2022)

Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy
por: Al-Mulla, Naima A, et al.
Publicado: (2014)

A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy
por: Chen, Shaozhen, et al.
Publicado: (2021)

Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization
por: Cogliati Dezza, Francesco, et al.
Publicado: (2023)

Laparoscopic Splenectomy in the Management of Benign and Malignant Hematologic Diseases
por: Silecchia, Gianfranco, et al.
Publicado: (2006)

Tumor-Associated Macrophages in Hematologic Malignancies: New Insights and Targeted Therapies
por: Petty, Amy J., et al.
Publicado: (2019)

Assessment and Management of Cardiotoxicity in Hematologic Malignancies
por: Bojan, Anca, et al.
Publicado: (2021)

1830. Epidemiology of Recurrent Bacterial Bloodstream Infections in the US Military Health System
por: Vostal, Alexander C, et al.
Publicado: (2022)

Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations
por: Cho, Sung-Yeon, et al.
Publicado: (2015)

Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
por: Zhang, Piaopiao, et al.
Publicado: (2020)

Breakthrough Bloodstream Infections Caused by Echinocandin-Resistant Candida tropicalis: An Emerging Threat to Immunocompromised Patients with Hematological Malignancies
por: Sfeir, Maroun M., et al.
Publicado: (2020)

Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?
por: Zimmer, Andrea J, et al.
Publicado: (2022)

A Visualized Mortality Prediction Score Model in Hematological Malignancies Patients with Carbapenem-Resistant Organisms Bloodstream Infection
por: Qian, Chenjing, et al.
Publicado: (2023)

Epidemiological and cytogenetic profiles of patients with hematological malignancies and their relationship with aging
por: Alves, Angelica de Souza Batista Maia, et al.
Publicado: (2018)

Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies
por: Allegra, Alessandro, et al.
Publicado: (2022)

Prophylaxis with levofloxacin: bacterial infections and antimicrobial resistance in hematological malignancies
por: Campos, Claudio Penido
Publicado: (2014)

Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases
por: Leone, Giuseppe, et al.
Publicado: (2015)

Epidemiology and Clinical Features of Bloodstream Infections in Hematology Wards: One Year Experience at the Catholic Blood and Marrow Transplantation Center
por: Kwon, Jae-Cheol, et al.
Publicado: (2013)

Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2012)

Evaluation of Bloodstream Infections During Chemotherapy-Induced Febrile Neutropenia in Patients with Malignant Hematological Diseases: Single Center Experience
por: Piukovics, Klára, et al.
Publicado: (2015)

Risk factors and clinical outcomes of breakthrough yeast bloodstream infections in patients with hematological malignancies in the era of newer antifungal agents
por: Kim, Si-Hyun, et al.
Publicado: (2018)

478. Outcomes of Extended-Spectrum β-Lactamase-Producing Escherichia coli Bloodstream Infection in Neutropenic Patients with Hematological Malignancies
por: Aslam, Sadaf, et al.
Publicado: (2019)

Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A 7-Year Retrospective Study
por: Wang, Shuyun, et al.
Publicado: (2023)

Insights Into the Characteristics of Sweet Syndrome in Patients With and Without Hematologic Malignancy
por: Zheng, Siting, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bmn9c5lln3djmepmqvucsbtr9s